Report Detail

Pharma & Healthcare Global (United States, European Union and China) Triptorelin Drug Market Research Report 2019-2025

  • RnM3672678
  • |
  • 16 August, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur®, is a GnRH agonist analogue. An agonist is a chemical that binds to a receptor of a cell and triggers a response by that cell. Triptorelin decreases the serum testosterone to castrate levels (estradiol in females).
In 2019, the market size of Triptorelin Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Triptorelin Drug.

This report studies the global market size of Triptorelin Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Triptorelin Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Allergan
Debiopharm Group
Ipsen
Xbrane Biopharma
Chengdu Tiantaishan pharmaceutical
Arbor Pharmaceuticals
Ferring
...

Market Segment by Product Type
3.75 mg Vial
11.25 mg Vial
22.5 mg Vial

Market Segment by Application
Advanced prostate cancer
Endometriosis
Uterine fibroids
Precocious puberty

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Triptorelin Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Triptorelin Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Triptorelin Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Triptorelin Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 3.75 mg Vial
      • 1.3.3 11.25 mg Vial
      • 1.3.4 22.5 mg Vial
    • 1.4 Market Segment by Application
      • 1.4.1 Global Triptorelin Drug Market Share by Application (2019-2025)
      • 1.4.2 Advanced prostate cancer
      • 1.4.3 Endometriosis
      • 1.4.4 Uterine fibroids
      • 1.4.5 Precocious puberty
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Triptorelin Drug Market Size
      • 2.1.1 Global Triptorelin Drug Revenue 2014-2025
      • 2.1.2 Global Triptorelin Drug Sales 2014-2025
    • 2.2 Triptorelin Drug Growth Rate by Regions
      • 2.2.1 Global Triptorelin Drug Sales by Regions 2014-2019
      • 2.2.2 Global Triptorelin Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Triptorelin Drug Sales by Manufacturers
      • 3.1.1 Triptorelin Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Triptorelin Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Triptorelin Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Triptorelin Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Triptorelin Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Triptorelin Drug Price by Manufacturers
    • 3.4 Key Manufacturers Triptorelin Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Triptorelin Drug Market
    • 3.6 Key Manufacturers Triptorelin Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 3.75 mg Vial Sales and Revenue (2014-2019)
      • 4.1.2 11.25 mg Vial Sales and Revenue (2014-2019)
      • 4.1.3 22.5 mg Vial Sales and Revenue (2014-2019)
    • 4.2 Global Triptorelin Drug Sales Market Share by Type
    • 4.3 Global Triptorelin Drug Revenue Market Share by Type
    • 4.4 Triptorelin Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Triptorelin Drug Sales by Application

    6 United States

    • 6.1 United States Triptorelin Drug Breakdown Data by Company
    • 6.2 United States Triptorelin Drug Breakdown Data by Type
    • 6.3 United States Triptorelin Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Triptorelin Drug Breakdown Data by Company
    • 7.2 European Union Triptorelin Drug Breakdown Data by Type
    • 7.3 European Union Triptorelin Drug Breakdown Data by Application

    8 China

    • 8.1 China Triptorelin Drug Breakdown Data by Company
    • 8.2 China Triptorelin Drug Breakdown Data by Type
    • 8.3 China Triptorelin Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Triptorelin Drug Breakdown Data by Company
    • 9.2 Rest of World Triptorelin Drug Breakdown Data by Type
    • 9.3 Rest of World Triptorelin Drug Breakdown Data by Application
    • 9.4 Rest of World Triptorelin Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Triptorelin Drug Sales by Countries
      • 9.4.2 Rest of World Triptorelin Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Allergan
      • 10.1.1 Allergan Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Triptorelin Drug
      • 10.1.4 Triptorelin Drug Product Introduction
      • 10.1.5 Allergan Recent Development
    • 10.2 Debiopharm Group
      • 10.2.1 Debiopharm Group Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Triptorelin Drug
      • 10.2.4 Triptorelin Drug Product Introduction
      • 10.2.5 Debiopharm Group Recent Development
    • 10.3 Ipsen
      • 10.3.1 Ipsen Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Triptorelin Drug
      • 10.3.4 Triptorelin Drug Product Introduction
      • 10.3.5 Ipsen Recent Development
    • 10.4 Xbrane Biopharma
      • 10.4.1 Xbrane Biopharma Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Triptorelin Drug
      • 10.4.4 Triptorelin Drug Product Introduction
      • 10.4.5 Xbrane Biopharma Recent Development
    • 10.5 Chengdu Tiantaishan pharmaceutical
      • 10.5.1 Chengdu Tiantaishan pharmaceutical Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Triptorelin Drug
      • 10.5.4 Triptorelin Drug Product Introduction
      • 10.5.5 Chengdu Tiantaishan pharmaceutical Recent Development
    • 10.6 Arbor Pharmaceuticals
      • 10.6.1 Arbor Pharmaceuticals Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Triptorelin Drug
      • 10.6.4 Triptorelin Drug Product Introduction
      • 10.6.5 Arbor Pharmaceuticals Recent Development
    • 10.7 Ferring
      • 10.7.1 Ferring Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Triptorelin Drug
      • 10.7.4 Triptorelin Drug Product Introduction
      • 10.7.5 Ferring Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Triptorelin Drug Sales Channels
      • 11.2.2 Triptorelin Drug Distributors
    • 11.3 Triptorelin Drug Customers

    12 Market Forecast

    • 12.1 Global Triptorelin Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Triptorelin Drug Sales Forecast by Type
    • 12.3 Global Triptorelin Drug Sales Forecast by Application
    • 12.4 Triptorelin Drug Forecast by Regions
      • 12.4.1 Global Triptorelin Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Triptorelin Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Triptorelin Drug. Industry analysis & Market Report on Triptorelin Drug is a syndicated market report, published as Global (United States, European Union and China) Triptorelin Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Triptorelin Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,568.24
      3,852.36
      5,136.48
      3,020.88
      4,531.32
      6,041.76
      514,533.60
      771,800.40
      1,029,067.20
      272,732.00
      409,098.00
      545,464.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report